• Am. J. Clin. Oncol. · Dec 2008

    Brain metastasis is an early manifestation of distant failure in stage III nonsmall cell lung cancer patients treated with radical chemoradiation therapy.

    • François Germain, Elaine S Wai, Eric Berthelet, Pauline T Truong, and Mary Lesperance.
    • Radiation Therapy Program, British Columbia Cancer Agency, Vancouver Island Centre, Victoria, BC, Canada
    • Am. J. Clin. Oncol. 2008 Dec 1; 31 (6): 561-6.

    ObjectivesTo evaluate the patterns of distant relapse, focusing on brain metastasis, in patients with stage III nonsmall cell lung cancer (NSCLC) treated with radical chemoradiation therapy (CRT).MethodsThe British Columbia Cancer Agency provincial database identified 2268 patients presenting with stage III NSCLC between January 1, 1990 and December 31, 2000. Of these, 120 patients received radical CRT, forming the study cohort. Variables analyzed included gender, age, Eastern Cooperative Oncology Group performance status, stage, histology, sites of metastasis, and survival. Univariate and multivariate analyses were performed.ResultsThe study cohort comprised 59 men and 61 women, median age 54.5 years. There were 74 stage IIIA and 46 stage IIIB cases. Histologic subtypes were squamous cell carcinoma (n = 29), adenocarcinoma (n = 53), and other non-squamous histologies (n = 38). Median follow-up time was 17.7 months. Median overall survival time was 19.2 months. Thirty-two patients (27%) developed brain metastasis. Non-brain metastases occurred in 51 patients (42%). No variables were statistically significantly associated with the risk of developing brain metastasis. Trends for higher risks of brain metastasis were observed with younger age (P = 0.09), and poor performance status (P = 0.07). Brain metastasis risk was highest during the first 10 months, progressively declining thereafter.ConclusionsStage III NSCLC patients treated with CRT have high risks of brain metastasis which persist during the first 10 months after diagnosis. Studies evaluating cranial prophylaxis will be relevant for these patients, particularly during this early period. Novel systemic therapies continue to be needed because non-brain metastases still represent the majority of distant recurrences.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.